Prevalence and risk factors for eye diseases, blindness, and low vision in Lhasa, Tibet

International Journal of Ophthalmology

Volumn 6, Issue 2, 2013, Pages 237-241

  Wang, Gui Qin ^a   Bai, Zong Xi ^b   Shi, Jing ^b   Luo, Sang ^b   Chang, Hong Fa ^b   Sai, Xiao Yong ^c  

^a NAVY GENERAL HOSPITAL   (China)

^b General Hospital of Tibet Military Command   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Blindness; Eye diseases; Low vision; Risk factors; Tibet

Indexed keywords

EID: 84894536991     PISSN: 22223959     EISSN: 22274898     Source Type: Journal    
DOI: 10.3980/j.issn.2222-3959.2013.02.24     Document Type: Article

References (38)

1. Sun LL, Liu H. Current status and rehabilitation of low vision in china. Medical Recapitulate. 2008; 14(12): 1850-1852.
2. Zhang LL, Yan H. Advance in epidemiology survey of ocular diseases. Chin J Rehabil Theory Pract. 2007; 13(9): 856-861.
3. Pizzarello L, Abiose A, Ffytche T., Duerksen R, Thulasiraj R, Taylor H., Faal H, Rao G, Kocur I., Resnikoff S. VISION 2020: The Right to Sight: a global initiative to eliminate avoidable blindness. Arch Ophthalmol. 2004; 122(4): 615-620.
4. Foster A, Resnikoff S. The impact of Vision 2020 on global blindness. Eye. 2005; 19(10): 1133-1135.
5. Hubley J, Gilbert C. Eye health promotion and the prevention of blindness in developing countries: critical issues. Br J Ophthalmol. 2006; 90(3): 279-284.
6. Zhao JL. "Vision 2020 Action" and Prevention of Blindness in China. Chin J Ophthalmol. 2002; 38(10): 577-579.
7. Chiang PP, O'Connor PM, Le Mesurier RT, Keeffe JE. A global survey of low vision service provision. Ophthalmic Epidemiol. 2011; 18(3): 109-121.
8. Dineen B, Foster A, Faal H. A proposed rapid methodology to assess the prevalence and causes of blindness and visual impairment. Ophthalmic Epidemiol. 2006; 13(1): 31-34.
9. Khandekar R, Mohammed AJ, Raisi AA. Prevalence and causes of blindness and low vision; before and five years after "VISION 2020" initiatives in Oman: a review. Ophthalmic Epidemiol. 2007; 14(1): 9-15.
10. Resnikoff S, Pascolini D, Etyaale D., Kocur I, Pararajasegaram R, Pokharel G.P., Mariotti SP. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004; 82(11): 844-851.
11. Yusup M, Chen XY. Epidemiology survey of visual loss. Int J Ophthalmol. 2010; 10(2): 304-307.
12. Hou BJ, De J, Wu H.Y., Gesang DZ, Bu PD, Qiangba SL, Tao H, Da W., Du AC, Luo B, Qin XP, Gao MF. Prevalence of blindness among adults aged 40 years or above in Linzhou county of Lasa. Chin J Ophthalmol. 2002; 38(10): 589-593.
13. Li JJ, Xu L. Epidemiologic Research Status on Visual Impairment in Middle Age and Elder. Int Rev Ophthalmol. 2006; 30(5): 354-357.
14. Leat SJ, Legge GE, Bullimore MA. What is low vision? A re-evaluation of definitions. Optom Vis Sci. 1999; 76(4): 198-211.
15. Faal H, Minassian DC, Dolin P.J., Mohamed AA, Ajewole J, Johnson GJ. Evaluation of a national eye care programme: re-survey after 10 years. Br J Ophthalmol. 2000; 84(9): 948-951.
16. Wu TY. Challenge to human being under environment of plateau and hypoxia. J Med Res. 2006; 35(10): 1-3.
17. Gallagher RP, Lee TK. Adverse effects of ultraviolet radiation: A brief review. Prog Biophys Mol Biol. 2006; 92(1): 119-131.
18. Guo B, Lu P, Chen X.M., Zhang WF, Chen RT. Prevalence of dry eye disease in mongolians at high altitude in China: The Henan Eye Study. Ophthalmic Epidemiol. 2010; 17(4): 234-241.
19. Bali J, Chaudhary KP, Thakur R. High altitude and the eye: a case controlled study in clinical ocular anthropometry of changes in the eye. High Alt Med Biol. 2005; 6(4): 327-338.
20. Sherwin JC, Kearns LS, Hewitt A.W., Ma Y., Kelly J, Griffiths LR, Mackey DA. Prevalence of chronic ocular diseases in a genetic isolate: the Norfolk Island Eye Study (NIES) Ophthalmic Epidemiol. 2011; 18(2): 61-71.
21. Ellerton JA, Zuljan I, Agazzi G. Eye problems in mountain and remote areas: prevention and onsite treatment-official recommendations of the International Commission For Mountain Emergency Medicine ICAR MEDCOM. Wilderness Environ Med. 2009; 20(2): 169-175.
22. Mader TH, Tabin G. Going to high altitude with preexisting ocular conditions. High Alt Med Biol. 2003; 4(4): 419-430.
23. Al Bdour M., Al Latayfeh MM. Risk factors for pterygium in an adult Jordanian population. Acta Ophthalmol Scand. 2004; 82(1): 64-67.
24. Gazzard G, Saw SM, Farook M, Koh D., Widjaja D, Chia SE, Hong C.Y., Tan DT. Pterygium in Indonesia: prevalence, severity and risk factors. Br J Oohthalmol. 2002; 86(12): 1341-1346.
25. Robman L, Taylor H. External factors in the development of cataract. Eye. 2005; 19(10): 1074-1082.
26. Huan XQ, Song LH. Risk factors of cataract formation. Int J Ophthalmol. 2010; 10(6): 1128-1130.
27. Li JQ, Qu C, Zhong SG. The correlation between long-wave ultraviolet and nuclear cataract. Zhonghua Yanwaishang Zhiye Yanbing Zazhi. 2010; 32(5): 397-400.
28. Wang HT, Bai ZX. Lhasa: Tibet People Press; 2011. High Altitude Ophthalmology and Otorhinolaryngology; pp. 50-57.
29. Zhao JL, Hu TS, Hu Z, Peng Y.E., Qu Z., Liao QZ. An epidemiological survey of primary angle-closure glaucoma (PACG) in Tibet. Chin J Ophthalmol. 1990; 26(1): 47-50.
30. Vajaranant TS, Nayak S, Wilensky J.T., Joslin CE. Gender and glaucoma: what we know and what we need to know. Curr Opin Ophthalmol. 2010; 21(2): 91-99.
31. Pasquale LR, Kang JH. Lifestyle, Nutrition, and Glaucoma. J Glaucoma. 2009; 18(6): 423-428.
32. Kosoko-Lasaki O., Gong G, Haynatzki G., Wilson MR. Race, ethnicity and prevalence of primary open-angle glaucoma. J Natl Med Assoc. 2006; 98(10): 1626-1629.
33. Hazin R, Hendrick AM, Kahook MY. Primary open-angle glaucoma: diagnostic approaches and management. J Natl Med Assoc. 2009; 101(1): 46-50.
34. Richman J, Lorenzana LL, Lankaranian D, Dugar J., Mayer JR, Wizov SS, Spaeth GL. Relationships in glaucoma patients between standard vision tests, quality of life, and ability to perform daily activities. Ophthalmic Epidemiol. 2010; 17(3): 144-151.
35. Huang S, Zheng Y, Foster P.J., Huang W., He M. Prevalence and causes of visual impairment in Chinese adults in urban southern China. Arch Ophthalmol. 2009; 127(10): 1362-1367.
36. Komolafe OO, Ashaye AO, Ajayi B.G., Bekibele CO. Visual impairment from age-related cataract among an indigenous African population. Eye(Lond) 2010; 24(1): 53-58.
37. Rao GN, Khanna R, Payal A. The global burden of cataract. Curr Opin Ophthalmol. 2010; 22(1): 4-9.
38. Brown RL, Barrett AE. Visual impairment and quality of life among older adults: an examination of explanations for the relationship. J Gerontol B Psychol Sci Soc Sci. 2011; 66(3): 364-373.